| Record ID | marc_loc_2016/BooksAll.2016.part29.utf8:237754114:923 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part29.utf8:237754114:923?format=raw |
LEADER: 00923cam a22002654a 4500
001 2002282749
003 DLC
005 20020926200612.0
008 020613s2000 txua b 001 0 eng
010 $a 2002282749
020 $a1587060221
040 $aDLC$cDLC$dDLC
042 $apcc
050 00 $aQP106.6$b.A525 2000
082 00 $a612.1/3$221
245 00 $aAngiogenesis inhibitors and stimulators :$bpotential therapeutic implications /$cShaker A. Mousa [editor].
260 $aGeorgetown, Tex. :$bLandes Bioscience ;$aAustin, Tex. :$bEurekah.com,$cc2000.
300 $a162 p. :$bill. ;$c24 cm.
440 0 $aMedical intelligence unit ;$v20
504 $aIncludes bibliographical references and index.
650 0 $aNeovascularization.
650 0 $aNeovascularization inhibitors.
650 0 $aGrowth factors.
700 1 $aMousa, Shaker A.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/fy022/2002282749.html